Revolution Medicines Inc. (RVMD)

NASDAQ: RVMD · Real-Time Price · USD

40.89

0.51 (1.26%)

At close: May 01, 2025, 3:53 PM

Revolution Medicines Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	11.58M	35.38M	29.39M	42.98M	50.04M	20.16M	n/a
Cost of Revenue	n/a	n/a	9.66M	7.33M	132.25M	91.75M	1.76M	1.19M
Gross Profit	n/a	11.58M	25.72M	22.06M	-89.27M	-41.71M	18.4M	-1.19M
Operating Income	-689.52M	-487.19M	-258.28M	-188.01M	-110.7M	-54.12M	-40.33M	-31.13M
Interest Income	86.88M	47.48M	9.15M	929K	2.24M	2.19M	777K	105K
Pretax Income	-600.85M	-439.89M	-249.13M	-187.09M	-108.53M	-52.04M	-41.79M	-31.13M
Net Income	-600.09M	-436.37M	-248.71M	-179.77M	-108.16M	-47.66M	-41.79M	-31.13M
Selling & General & Admin	97.3M	75.62M	40.59M	30.45M	21.43M	12.41M	9.41M	4.54M
Research & Development	592.23M	423.14M	253.07M	186.95M	132.25M	91.75M	51.08M	26.59M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-2.12M	n/a
Operating Expenses	689.52M	498.76M	293.66M	217.4M	153.68M	104.16M	60.49M	31.13M
Interest Expense	n/a	303K	n/a	12K	71K	106K	116K	103K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	498.76M	293.66M	217.4M	153.68M	104.16M	60.49M	31.13M
Income Tax Expense	753K	-3.52M	-420K	-7.32M	-371K	-4.37M	-1.34M	105K
Shares Outstanding (Basic)	167.74M	113.15M	80.63M	72.81M	66.6M	59M	36.47M	36.47M
Shares Outstanding (Diluted)	167.74M	113.15M	80.63M	72.81M	66.6M	59M	36.47M	36.47M
EPS (Basic)	-3.58	-3.86	-3.08	-2.47	-1.62	-0.81	-1.15	-0.85
EPS (Diluted)	-3.58	-3.86	-3.08	-2.47	-1.62	-0.81	-1.15	-0.85
EBITDA	-689.52M	-430.58M	-239.47M	-179.75M	-101.91M	-48.59M	-39.91M	-29.84M
EBIT	n/a	-439.59M	-249.13M	-187.08M	-108.46M	-51.93M	-41.67M	-31.02M
Depreciation & Amortization	n/a	9.31M	9.66M	7.33M	6.54M	3.34M	1.76M	1.19M